Moderna eyes Omicron-specific jab in 2022

By Georgie Moore and Dominic Giannini
Updated January 27 2022 - 8:41am, first published 8:35am
Pharmaceutical company Moderna is testing its Omicron-specific COVID-19 booster vaccine.

Pharmaceutical company Moderna aims to have its Omicron-specific COVID-19 booster vaccine on the market by the third quarter of 2022.

Advertisement

Ad

Get the latest Newcastle news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.